Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Interim period ended September 30, 2024
Filing Date: November 25, 2024
Headquarters: Vancouver, British Columbia, Canada
This filing serves as a cover document submitting condensed consolidated interim financial statements and Management's Discussion and Analysis (MD&A) for the three and nine months ended September 30, 2024.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached exhibits (Exhibit 99.1 and 99.2) which are not included in the input text.
- Revenue: Not provided in text.
- Net Income/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Debt & Liquidity: Not provided in text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached MD&A (Exhibit 99.2) for comparative analysis.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, or contingencies are detailed in the cover document. These disclosures are contained within the attached Management's Discussion and Analysis (Exhibit 99.2).
Investor Verification Checklist
- Review Exhibit 99.1 for the Condensed Consolidated Interim Financial Statements to verify revenue, net loss, and cash position.
- Review Exhibit 99.2 for Management's Discussion and Analysis to understand operational progress and liquidity risks.
- Confirm the status of the company's working capital and funding requirements as of September 30, 2024.
- Verify the certifications signed by the CEO and CFO (Exhibits 99.3 and 99.4) regarding the accuracy of the interim filings.